We are live on ! Find out more
ALPN

Alpine Immune Sciences Inc
ALPN

Delisted

ALPN was delisted on the 17th of May, 2024.

Back to rankings

58 hedge funds and large institutions have $55.4M invested in Alpine Immune Sciences Inc in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 11

2% less funds holding

Funds holding: 59 → 58 (-1)

11% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 9

46% less capital invested

Capital invested by funds: $103M → $55.4M (-$48M)

Holders
58
Holders Change
-1
Holders Change %
-1.69%
% of All Funds
1.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
19
Reduced
11
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$1.76M
2
SM
Sabby Management
Florida
+$793K
3
EAM
EverPoint Asset Management
Connecticut
+$626K
4
OM
Opaleye Management
Massachusetts
+$501K
5
BCM
Bridgeway Capital Management
Texas
+$375K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$1.75M
2
MCM
Marsico Capital Management
Colorado
-$1.06M
3
SFM
Sphera Funds Management
Israel
-$759K
4
KCM
Kingdon Capital Management
New York
-$716K
5
SIM
Spark Investment Management
New York
-$332K
Name Holding Trade Value Shares
Change 		Change in
Stake
SO
51
STRS Ohio
Ohio
$6K – – –
BA
52
BlackRock Advisors
Delaware
$5K +$2.2K +110 +56%
Deutsche Bank
53
Deutsche Bank
Germany
$3K -$2.52K -126 -41%
BJ
54
BlackRock Japan
Japan
$3K +$3.3K +165 New
Creative Planning
55
Creative Planning
Kansas
$2K – – –
MTIP
56
Magee Thomson Investment Partners
California
$1K – – –
Wells Fargo
57
Wells Fargo
California
$1K +$1.7K +85 +1,700%
Geode Capital Management
58
Geode Capital Management
Massachusetts
$139 -$220 -11 -0.1%
MCM
59
Marsico Capital Management
Colorado
– -$1.06M -34,108 Closed
SIM
60
Spark Investment Management
New York
– -$332K -10,750 Closed
GP
61
GLG Partners
United Kingdom
– -$300K -9,689 Closed
FAM
62
Fred Alger Management
New York
– -$287K -9,275 Closed
Citadel Advisors
63
Citadel Advisors
Florida
– -$176K -5,690 Closed
USAA
64
United Services Automobile Association
Texas
– -$176K -5,688 Closed
DTL
65
Dynamic Technology Lab
Singapore
– -$78K -2,527 Closed
GL
66
GLG LLC
New York
– -$29K -943 Closed
BNP Paribas Financial Markets
67
BNP Paribas Financial Markets
France
– -$6.63K -214 Closed
1 2
3

ALPN Hedge Fund Activity: Q1 2016 in Review

58 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q1 2016, worth a combined $55.4M — down 46% from $103M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of ALPN and 8 opened new positions — a net loss of 1 holder — while 11 trimmed existing stakes and 19 added.

The largest buyer was BVF Inc, adding an estimated $1.76M. The largest seller was Goldman Sachs, cutting an estimated $1.75M.

  • 58 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q1 2016, down from 59 in Q4 2015.
  • Funds reported $55.4M of Alpine Immune Sciences Inc stock for Q1 2016, down 46% quarter-over-quarter.
  • 8 funds opened new Alpine Immune Sciences Inc positions in Q1 2016 and 9 closed out, a net change of -1 holder.
  • The largest Alpine Immune Sciences Inc buyer in Q1 2016 was BVF Inc, an estimated $1.76M added.
  • The largest Alpine Immune Sciences Inc seller in Q1 2016 was Goldman Sachs, an estimated $1.75M sold.

Based on aggregated 13F filings for Q1 2016.